NX

The FY2025 numbers look superficially like growth — revenue up 43.8% to $1.84B — but the entire increase is the August 2024 Tyman acquisition (14.1M new shares plus ~$504M cash consideration disclosed in MD&A), not organic demand. The deal has been a disaster on arrival: FY2025 swung to a $251M net loss and a $194M operating loss versus $33M of net income in FY2024, and the 10-K explicitly discloses a Q4 2025 goodwill impairment trigger 'related to the decline in the Company's stock price,' with the auditor flagging the quantitative goodwill impairment of every reporting unit as the critical audit matter. Stockholders' equity fell 28.2% in one year and retained earnings collapsed 61.7% to $165M — this is real capital destruction, not a non-cash optical event you can wave away.

The red flag that elevates this from 'sell' to 'avoid' is buried in the auditor's report: 'our report dated December 12, 2025 expressed an adverse opinion' on internal control over financial reporting. An adverse ICFR opinion alongside a freshly-closed transformative acquisition, a segment restructuring (now three segments: Hardware, Extruded, Custom Solutions), and a goodwill writedown is the textbook setup for further surprises — restatements, additional impairments, or covenant issues. Liabilities/equity climbed to 1.71x, cash is only $76M against the post-deal capital structure, and management is still buying back stock ($32.4M) and paying a dividend ($14.9M) into this.